TriVerity: A New Approach to Diagnosing Acute Infection in the Emergency Department скачать в хорошем качестве

TriVerity: A New Approach to Diagnosing Acute Infection in the Emergency Department

TriVerity™ is an FDA-cleared rapid blood test that reduces diagnostic uncertainty for patients with suspected acute infection or sepsis in the emergency department where early decisions have the greatest impact on patient outcomes and hospital operations. Using host immune response profiling and machine learning, TriVerity delivers in ~30 minutes three actionable results from a single blood draw: likelihood of bacterial infection, likelihood of viral infection, and risk of severe illness over the next seven days. TriVerity answers three critical questions that drive ED disposition decisions in real time: • Is there a bacterial or viral infection? • How sick is this patient likely to become? • Who needs escalation versus who can safely go home? For emergency clinicians — TriVerity delivers diagnostic and prognostic clarity to help clinicians make faster, safer, more confident patient disposition decisions. For laboratory leaders — TriVerity is a high clinical impact test that elevates the lab's role in acute infection and sepsis care. For hospital executives — TriVerity enables better clinical decision-making at the earliest point of patient care, driving quality, efficiency, and financial sustainability. Designed for the realities of acute care, the TriVerity Test and Myrna™ Instrument combine minimal hands-on time, integrated safety checks, and rapid turnaround to fit seamlessly into existing ED and laboratory operations. Learn more: inflammatix.com/triverity/